KDELR1: A Potential Drug Target and Biomarker for Endoplasmic Reticulum Protein Retention

Target Name: KDELR1

NCBI ID: G10945

KDELR1

KDELR1: A Potential Drug Target and Biomarker for Endoplasmic Reticulum Protein Retention

Endoplasmic reticulum (ER) is a vital organ in eukaryotic cells responsible for the quality control and delivery of proteins synthesized in the cytoplasm. The ER is also the site of protein storage, degradation, and retrieval. The KDELR1 protein is a key regulator of ER function and has been extensively studied in the context of various cellular processes. In this article, we will discuss the potential implications of KDELR1 as a drug target and biomarker.

KDELR1: Structure and Function

KDELR1 is a 21-kDa protein that belongs to the family of transmembrane proteins known as ENSRTs (endoplasmic reticulum retention proteins). The protein is encoded in the human genome as KDEL1 and has a predicted localization in the ER membrane. KDELR1 functions as a protein-protein interaction (PPI) partner, specifically interacting with the protein known as KDEL2. This interaction between KDELR1 and KDEL2 is critical for the regulation of ER retention and protein delivery.

KDELR1 plays a vital role in the ER retention and delivery process. It interacts with KDEL2, which is a known regulator of the endoplasmic reticulum transmembrane protein (TM) traffic. TMPs are involved in the delivery of various proteins to the ER, including cytoskeletal components, enzymes, and signaling molecules. The KDELR1-KDEL2 interaction allows for the regulation of TMT (transmembrane traffic) events, which are critical for the delivery of specific proteins to their final destination in the ER.

In addition to its role in TMT regulation, KDELR1 has been shown to play a crucial role in the degradation of misfolded proteins. Misfolded proteins are generated during the translation process and can either be retained in the ER for degradation or released into the cytoplasm to participate in various cellular processes. KDELR1 has been shown to promote the degradation of misfolded proteins by activating the ubiquitin-proteasome system (UPS). This process is critical for the elimination of misfolded proteins, which can contribute to the development of various diseases, including neurodegenerative disorders, cancer, and autoimmune diseases.

KDELR1 as a Drug Target

KDELR1 has the potential to serve as a drug target due to its involvement in various cellular processes that can be targeted by small molecules. One of the potential drug targets for KDELR1 is the regulation of ER retention and protein delivery. Drugs that can modulate TMT events or degradation can potentially be used to treat various diseases associated with misfolded proteins, such as neurodegenerative disorders, cancer, and autoimmune diseases.

Another potential drug target for KDELR1 is its role in the regulation of UPS function. The UPS is a critical mechanism for the elimination of misfolded proteins, and drugs that can inhibit its function can potentially be used to treat various diseases. For example, UPS inhibitors have been shown to be effective in treating neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.

KDELR1 as a Biomarker

KDELR1 can also serve as a biomarker for various diseases associated with misfolded proteins. The levels of KDELR1 in endoplasmic reticulum (ER) fractions can be used as an indicator of the delivery status of misfolded proteins. This can be useful for tracking the efficacy of drugs that target TMT events or degradation. In addition, KDELR1 levels can be used as a biomarker for certain neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease.

Conclusion

In conclusion, KDELR1 is a protein that plays a vital role in the regulation of endoplasmic reticulum (ER) function, including the retention and delivery of proteins. Its interaction with KDEL2 and the regulation of TMT events and protein degradation are potential drug targets for the treatment of various diseases associated with misfolded proteins. The potential use of KDELR1 as a biomarker for the detection and treatment of such diseases makes it an attractive target for future research.

Protein Name: KDEL Endoplasmic Reticulum Protein Retention Receptor 1

Functions: Receptor for the C-terminal sequence motif K-D-E-L that is present on endoplasmic reticulum resident proteins and that mediates their recycling from the Golgi back to the endoplasmic reticulum

The "KDELR1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KDELR1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets